Register entry
CERVEAU TECHNOLOGIES INC A LANTHEUS CO
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 2
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
2| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10022461 | TAUKLARIFYflorquinitau f-18 | use | Jun 2035 |
| 9808542 | TAUKLARIFYflorquinitau f-18 | substance, product | Jun 2035 |
| Product | Exclusivity | Until |
|---|---|---|
| TAUKLARIFYFLORQUINITAU F-18 | NCE New chemical entity | Aug 2031 |
Enquiry
Common questions
- Is CERVEAU TECHNOLOGIES INC A LANTHEUS CO FDA approved?
- CERVEAU TECHNOLOGIES INC A LANTHEUS CO holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.